AMN Healthcare reported Q2 2023 consolidated revenue of $991.3 million, a 31% decrease from the prior year and 12% lower than the prior quarter. GAAP EPS was $1.55, and adjusted EPS was $2.38. The company is focused on technology enablement and strategic talent solutions.
Consolidated revenue for the quarter was $991.3 million, a 31% decrease from prior year.
Net income was $61 million, or $1.55 per diluted share.
Adjusted diluted EPS in the second quarter was $2.38.
The company spent $425 million year to date to repurchase 4.1 million shares of common stock.
Revenue in the third quarter of 2023 is expected to be 24-26% lower than prior year and 13-15% lower sequentially.
Visualization of income flow from segment revenue to net income